Phase I study protocol for ex vivo lentiviral gene therapy for the inherited skin disease, Netherton syndrome. (2013)
Attributed to:
BRIC: Packaging cell lines for inherently manufacturable viral vectors
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1089/humc.2013.195
PubMed Identifier: 24329107
Publication URI: http://europepmc.org/abstract/MED/24329107
Type: Journal Article/Review
Volume: 24
Parent Publication: Human gene therapy. Clinical development
Issue: 4
ISSN: 2324-8637